Refractory Vasodilatory Shock

May 15, 2019 00:29:21
Refractory Vasodilatory Shock
Critical Care Perspectives in Emergency Medicine
Refractory Vasodilatory Shock
/

Show Notes

Emergency medicine, critical care, and acute care providers evaluate, resuscitate, and manage patients with shock on a daily basis.  Despite initial efforts, a select number of patients are refractory to fluid and vasopressor administration.  In this podcast, we discuss a rationale approach to vasopressor administration, along with several rescue therapies for the patient with refractory vasodilatory shock.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions!

Other Episodes

Episode

December 27, 2019 00:23:35
Episode Cover

Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus. Download Companion HandoutDownload You can get CME credit for this episode here!Click here for CME Account Creation Instructions ...

Listen

Episode

May 13, 2020 00:21:18
Episode Cover

COVID-19: Toxicities of Potential Therapies

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19. Download Companion HandoutDownload You can get CME credit for this episode here!Click here for CME Account Creation Instructions ...

Listen

Episode

September 27, 2021 00:25:40
Episode Cover

Milrinone or Dobutamine for Cardiogenic Shock?

Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.  With respect to inotropic medications, there is little data to guide optimal management and selection of agents.  In this podcast we discuss the results of a recent trial that compared milrinone with dobutamine for patients with cardiogenic shock.  Which agent was the winner? Download Companion HandoutDownload You can get CME credit for this episode hereClick here for CME Account Creation Instructions ...

Listen